These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6235977)

  • 1. Effect of guanosine on antitumor activity of fluorinated pyrimidines against P 388 leukemia.
    Iigo M; Hoshi A
    Cancer Chemother Pharmacol; 1984; 13(2):86-90. PubMed ID: 6235977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of the chemotherapeutic action of 5'-deoxy-5-fluorouridine in combination with guanosine and related compounds.
    Iigo M; Miwa M; Ishitsuka H; Nitta K
    Cancer Chemother Pharmacol; 1987; 19(1):61-4. PubMed ID: 3028664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between antitumor effect and metabolites of 5-fluorouracil in combination treatment with 5-fluorouracil and guanosine in ascites sarcoma 180 tumor system.
    Iigo M; Kuretani K; Hoshi A
    Cancer Res; 1983 Dec; 43(12 Pt 1):5687-94. PubMed ID: 6640523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of molar ratio on the combination effect of 5-fluorouracil with guanosine 5'-monophosphate on P388 and L1210 leukemias.
    Iigo M; Hoshi A
    Eur J Cancer Clin Oncol; 1984 Mar; 20(3):411-5. PubMed ID: 6323189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pyrimidines, purines and their nucleosides on antitumor activity of 5-fluorouracil against L-1210 leukemia.
    Iigo M; Ando N; Hoshi A; Kuretani K
    J Pharmacobiodyn; 1982 Jul; 5(7):515-20. PubMed ID: 7131236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative studies on the antitumor activity of the fluorinated pyrimidines 5'-DFUR, tegafur, UFT and FUra on various murine tumors].
    Miwa M; Eda H; Fukuda H; Fujimoto K; Ishitsuka H
    Gan To Kagaku Ryoho; 1988 May; 15(5):1755-63. PubMed ID: 2967051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of antitumor activity of 5-fluoro-2'-deoxyuridine by guanosine-5'-monophosphate.
    Iigo M; Hoshi A
    J Pharmacobiodyn; 1984 Jan; 7(1):67-9. PubMed ID: 6327964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo potentiation of 5-fluorouracil cytotoxicity against AKR leukemia by purines, pyrimidines, and their nucleosides and deoxynucleosides.
    Santelli G; Valeriote F
    J Natl Cancer Inst; 1980 Jan; 64(1):69-72. PubMed ID: 6928048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of (E)-5-(2-bromovinyl)uracil on the catabolism and antitumor activity of 5-fluorouracil in rats and leukemic mice.
    Desgranges C; Razaka G; De Clercq E; Herdewijn P; Balzarini J; Drouillet F; Bricaud H
    Cancer Res; 1986 Mar; 46(3):1094-101. PubMed ID: 3943086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis of 5-fluorouracil action against various cancer cells.
    Inaba M; Mitsuhashi J; Ozawa S
    Jpn J Cancer Res; 1990 Oct; 81(10):1039-44. PubMed ID: 2146239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
    Klubes P; Cerna I
    Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical mechanisms for the scheduled synergism of (alpha S, 5S)-2 amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid and 5-fluorouracil in P388 leukemia.
    Ardalan B; Chandrasekaran B; Hrishikeshavan HJ
    Cancer Chemother Pharmacol; 1985; 15(1):44-8. PubMed ID: 2408773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
    Boothman DA; Briggle TV; Greer S
    Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on 18F-labeled pyrimidines. II. Metabolic investigation of 18F-5-fluorouracil, 18F-5-fluoro-2'-deoxyuridine and 18F-5-fluorouridine in rats.
    Ishiwata K; Ido T; Kawashima K; Murakami M; Takahashi T
    Eur J Nucl Med; 1984; 9(4):185-9. PubMed ID: 6232143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of plasma 5-fluorouracil nucleoside levels in patients with metastatic breast cancer: relationships with toxicities.
    Barberi-Heyob M; Weber B; Merlin JL; Dittrich C; de Bruijn EA; Luporsi E; Guillemin F
    Cancer Chemother Pharmacol; 1995; 37(1-2):110-6. PubMed ID: 7497579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic antitumor effect of fluoropyrimidines and polyinosinic-polycytidylic acid against L1210 leukemia.
    Iigo M; Chapekar MS; Glazer RI
    Cancer Res; 1985 Sep; 45(9):4039-42. PubMed ID: 2411395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic response of leukemic mice treated with fluorinated pyrimidines and inhibitors of deoxyuridylate synthesis.
    Moran RG; Danenberg PV; Heidelberger C
    Biochem Pharmacol; 1982 Sep; 31(18):2929-35. PubMed ID: 6215922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of plasma levels of fluorinated pyrimidines by guanosine 5'-monophosphate.
    Iigo M; Yamaizumi Z; Nishimura S; Hoshi A
    Cancer Chemother Pharmacol; 1987; 20(1):1-4. PubMed ID: 3040286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation by dipyridamole of 5-fluorouridine antitumor activity against a rat adenocarcinoma in vivo.
    el Hag IA; Roos G; Jönsson PE; Stenram U
    Anticancer Res; 1990; 10(1):29-32. PubMed ID: 2139770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on 18F-labeled pyrimidines III. Biochemical investigation of 18F-labeled pyrimidines and comparison with 3H-deoxythymidine in tumor-bearing rats and mice.
    Ishiwata K; Ido T; Abe Y; Matsuzawa T; Murakami M
    Eur J Nucl Med; 1985; 10(1-2):39-44. PubMed ID: 3156740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.